|
OMIM |
Link |
Information gain |
01 |
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.00322026
|
|
|
UL
|
[NCBI]
|
0.00230594
|
|
|
hyperpigmentation, familial progressive
|
[NCBI]
|
0.00230594
|
|
|
AN
|
[NCBI]
|
0.00230594
|
|
|
EC1
|
[NCBI]
|
0.00178344
|
|
|
xm system
|
[NCBI]
|
0.00158672
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.00123147
|
|
|
ST3
|
[NCBI]
|
0.00104895
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000984686
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
0.00029812
|
|
|
blood group--froese
|
[NCBI]
|
0.000249114
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
0.000249114
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000240956
|
|
|
australia antigen
|
[NCBI]
|
0.000209874
|
|
|
ITGB3
|
[NCBI]
|
0.000202057
|
|
|
blood group--private systems
|
[NCBI]
|
0.000155954
|
|
|
ITGA2
|
[NCBI]
|
0.000137764
|
|
|
pa polymorphism of alpha-2-globulin
|
[NCBI]
|
0.000124387
|
|
|
KN
|
[NCBI]
|
0.000124387
|
|
|
PSORS1
|
[NCBI]
|
0.000114561
|
|
|
xh antigen
|
[NCBI]
|
0.000112488
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
0.000112488
|
|
|
HLA-DRA
|
[NCBI]
|
0.000107042
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
0.000104768
|
|
|
raph blood group system
|
[NCBI]
|
0.000104768
|
|
|
RD
|
[NCBI]
|
0.000104768
|
|
|
neutrophil-specific antigen 1
|
[NCBI]
|
0.000102444
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000101533
|
|
|
IN
|
[NCBI]
|
9.90346e-05
|
|
|
SW
|
[NCBI]
|
9.44702e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
8.89753e-05
|
|
|
reifenstein syndrome
|
[NCBI]
|
8.7436e-05
|
|
|
RHN
|
[NCBI]
|
8.46042e-05
|
|
|
SCZD9
|
[NCBI]
|
8.46042e-05
|
|
|
SC
|
[NCBI]
|
8.46042e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
8.20911e-05
|
|
|
TNFSF4
|
[NCBI]
|
7.83878e-05
|
|
|
Ii
|
[NCBI]
|
7.59051e-05
|
|
|
ART4
|
[NCBI]
|
7.43415e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
6.83552e-05
|
|
|
HLA-A
|
[NCBI]
|
6.49615e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
6.43499e-05
|
|
|
ITGA2B
|
[NCBI]
|
6.29461e-05
|
|
|
CD109
|
[NCBI]
|
6.14598e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
5.99675e-05
|
|
|
TNFSF6
|
[NCBI]
|
5.75708e-05
|
|
|
CEACAM5
|
[NCBI]
|
5.65215e-05
|
|
|
ERMAP
|
[NCBI]
|
5.58645e-05
|
|
|
RHCE
|
[NCBI]
|
5.39156e-05
|
|
|
IL2
|
[NCBI]
|
5.06041e-05
|
|
|
CD151
|
[NCBI]
|
4.84081e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
4.33893e-05
|
|
|
FCGR3A
|
[NCBI]
|
4.27435e-05
|
|
|
LDHB
|
[NCBI]
|
3.74427e-05
|
|
|
MCP
|
[NCBI]
|
3.27847e-05
|
|
|
MS
|
[NCBI]
|
3.26709e-05
|
|
|
CF
|
[NCBI]
|
3.16309e-05
|
|
|
SLE
|
[NCBI]
|
3.14379e-05
|
|
|
ALPS
|
[NCBI]
|
3.07279e-05
|
|
|
hepatocellular carcinoma-associated antigen 112
|
[NCBI]
|
3.07176e-05
|
|
|
FOXP3
|
[NCBI]
|
2.79577e-05
|
|
|
GCNT1
|
[NCBI]
|
2.792e-05
|
|
|
PHF20
|
[NCBI]
|
2.792e-05
|
|
|
CD36
|
[NCBI]
|
2.69528e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
2.61047e-05
|
|
|
CD5
|
[NCBI]
|
2.61047e-05
|
|
|
HLA-MT
|
[NCBI]
|
2.61047e-05
|
|
|
MAGEE1
|
[NCBI]
|
2.4756e-05
|
|
|
MUC1
|
[NCBI]
|
2.45709e-05
|
|
|
CHS
|
[NCBI]
|
2.39946e-05
|
|
|
HSPA6
|
[NCBI]
|
2.3682e-05
|
|
|
IL21
|
[NCBI]
|
2.27897e-05
|
|
|
HPA-2
|
[NCBI]
|
2.27897e-05
|
|
|
CD7
|
[NCBI]
|
2.27897e-05
|
|
|
IL21R
|
[NCBI]
|
2.13596e-05
|
|
|
GCNT2
|
[NCBI]
|
2.07677e-05
|
|
|
PRH2
|
[NCBI]
|
2.07677e-05
|
|
|
CXCL10
|
[NCBI]
|
2.02356e-05
|
|
|
CFD
|
[NCBI]
|
1.97524e-05
|
|
|
INDO
|
[NCBI]
|
1.8902e-05
|
|
|
TF
|
[NCBI]
|
1.84616e-05
|
|
|
LU
|
[NCBI]
|
1.81705e-05
|
|
|
THY1
|
[NCBI]
|
1.72357e-05
|
|
|
HR
|
[NCBI]
|
1.72357e-05
|
|
|
Ge
|
[NCBI]
|
1.69581e-05
|
|
|
HLA-G
|
[NCBI]
|
1.64437e-05
|
|
|
GIST
|
[NCBI]
|
1.62532e-05
|
|
|
ITGB1
|
[NCBI]
|
1.62046e-05
|
|
|
JAK2
|
[NCBI]
|
1.60557e-05
|
|
|
AT
|
[NCBI]
|
1.58418e-05
|
|
|
CD59
|
[NCBI]
|
1.55472e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.53455e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.47841e-05
|
|
|
COL4A3
|
[NCBI]
|
1.46099e-05
|
|
|
GP1BA
|
[NCBI]
|
1.44414e-05
|
|
|
AVPR2
|
[NCBI]
|
1.3674e-05
|
|
|
SLAMF1
|
[NCBI]
|
1.35336e-05
|
|
|
ABO
|
[NCBI]
|
1.3264e-05
|
|
|
CTLA4
|
[NCBI]
|
1.27647e-05
|
|
|
WAS
|
[NCBI]
|
1.26283e-05
|
|
|
DES
|
[NCBI]
|
1.25326e-05
|
|
|
CVID
|
[NCBI]
|
1.22567e-05
|
|
|
C4B
|
[NCBI]
|
1.22036e-05
|
|
|
CTSC
|
[NCBI]
|
1.20986e-05
|
|
|
IGHG1
|
[NCBI]
|
1.16997e-05
|
|
|
REN
|
[NCBI]
|
1.12429e-05
|
|
|
TBG
|
[NCBI]
|
1.12429e-05
|
|
|
CSF3
|
[NCBI]
|
1.09059e-05
|
|
|
TFPI2
|
[NCBI]
|
1.09059e-05
|
|
|
CEACAM1
|
[NCBI]
|
1.05154e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.00853e-05
|
|
|
SLC4A1
|
[NCBI]
|
9.88398e-06
|
|
|
HP
|
[NCBI]
|
7.85484e-06
|
|
|
SI
|
[NCBI]
|
7.76287e-06
|
|
|
VIM
|
[NCBI]
|
7.5613e-06
|
|
|
ESD
|
[NCBI]
|
7.52208e-06
|
|
|
PRL
|
[NCBI]
|
7.22864e-06
|
|
|
ACHE
|
[NCBI]
|
7.1357e-06
|
|
|
ALB
|
[NCBI]
|
6.49639e-06
|
|
|
ADA
|
[NCBI]
|
6.27566e-06
|
|
|
NGFR
|
[NCBI]
|
6.1079e-06
|
|
|
EPOR
|
[NCBI]
|
5.21514e-06
|
|
|
RA
|
[NCBI]
|
5.17439e-06
|
|
|
PCNA
|
[NCBI]
|
5.02198e-06
|
|
|
DCK
|
[NCBI]
|
4.719e-06
|
|
|
EPO
|
[NCBI]
|
4.41153e-06
|
|
|
GFAP
|
[NCBI]
|
4.39437e-06
|
|
|
TNF
|
[NCBI]
|
3.14294e-06
|
|
|
CD
|
[NCBI]
|
2.66649e-06
|
|
|
CP
|
[NCBI]
|
2.28644e-06
|
|
|
MBP
|
[NCBI]
|
1.82842e-06
|
|
|
KLK3
|
[NCBI]
|
1.71621e-06
|
|
|
TLR4
|
[NCBI]
|
1.0689e-06
|
|
|
AFP
|
[NCBI]
|
6.03657e-07
|
|
|
FRAP1
|
[NCBI]
|
5.63326e-07
|
|
|
EGFR
|
[NCBI]
|
3.93603e-07
|
|
|
APOB
|
[NCBI]
|
9.0348e-08
|
|
|
TG
|
[NCBI]
|
4.31757e-08
|
|